Key facts
- This page summarizes William E. Cohn's Form 4 filing for Cardiovascular Systems Inc.
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2022, 16:11.
William E. Cohn - 05 Aug 2022 Form 4 Insider Report for Cardiovascular Systems Inc
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 05 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2022, 16:11:16 UTC
- Prior SEC filing
- 11 Aug 2021
- Next SEC filing
- 27 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Nick as Attorney-in-Fact for William E. Cohn pursuant to Power of Attorney previously filed.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William E. Cohn filed Form 4 for Cardiovascular Systems Inc on 09 Aug 2022.
Change
- Previous filing in this sequence was filed on 11 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSII
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,626
- Change %
- +62%
- Price
- $0.000000
- Shares after
- 9,449
- Date
- 05 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSII
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +9,064
- Change %
- Price
- $0.000000
- Shares after
- 9,064
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,064
- Exercise price
- Footnotes
- F3
CSII
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 31,489
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,489
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents restricted stock received at the election of the reporting person, in lieu of cash payment, as a retainer for service as a director of the Company during fiscal year 2023.
Footnote F2
Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
Footnote F3
Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 2,266 shares on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.